Oppenheimer Comments on Personalis, Inc.’s FY2020 Earnings (NASDAQ:PSNL)


Share on StockTwits

Personalis, Inc. (NASDAQ:PSNL) – Analysts at Oppenheimer upped their FY2020 earnings per share (EPS) estimates for shares of Personalis in a note issued to investors on Tuesday, January 12th. Oppenheimer analyst K. Degeeter now anticipates that the company will earn ($1.08) per share for the year, up from their previous estimate of ($1.11). Oppenheimer has a “Hold” rating on the stock. Oppenheimer also issued estimates for Personalis’ Q4 2020 earnings at ($0.24) EPS, Q2 2021 earnings at ($0.28) EPS, Q4 2021 earnings at ($0.28) EPS, FY2021 earnings at ($1.10) EPS and FY2022 earnings at ($1.11) EPS.

Personalis (NASDAQ:PSNL) last posted its quarterly earnings data on Thursday, November 5th. The company reported ($0.27) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.29) by $0.02. Personalis had a negative net margin of 43.16% and a negative return on equity of 31.11%. The company had revenue of $19.82 million for the quarter, compared to analyst estimates of $19.25 million.

Several other equities research analysts also recently weighed in on PSNL. Morgan Stanley lifted their price target on shares of Personalis from $25.00 to $27.00 and gave the company an “overweight” rating in a research note on Monday, November 9th. Zacks Investment Research lowered Personalis from a “hold” rating to a “sell” rating in a research report on Tuesday, January 5th. Bank of America lowered Personalis from a “buy” rating to a “neutral” rating and set a $40.00 target price for the company. in a research report on Monday, January 4th. They noted that the move was a valuation call. Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell boosted their target price on Personalis from $35.00 to $45.00 in a research report on Wednesday, December 16th. Finally, HC Wainwright boosted their target price on Personalis from $30.00 to $50.00 and gave the company a “buy” rating in a research report on Wednesday. One investment analyst has rated the stock with a sell rating, four have given a hold rating and six have issued a buy rating to the company. Personalis has an average rating of “Hold” and an average target price of $34.78.

Shares of NASDAQ PSNL opened at $40.93 on Thursday. The firm has a market cap of $1.59 billion, a PE ratio of -40.52 and a beta of 1.87. The company’s fifty day simple moving average is $35.55 and its 200 day simple moving average is $25.56. Personalis has a 12-month low of $4.27 and a 12-month high of $46.80.

A number of hedge funds have recently added to or reduced their stakes in the business. JPMorgan Chase & Co. boosted its stake in Personalis by 122.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 3,616,272 shares of the company’s stock valued at $79,992,000 after purchasing an additional 1,987,582 shares during the last quarter. ARK Investment Management LLC boosted its stake in shares of Personalis by 59.2% in the 3rd quarter. ARK Investment Management LLC now owns 3,293,141 shares of the company’s stock worth $71,362,000 after buying an additional 1,224,458 shares during the last quarter. BlackRock Inc. boosted its stake in shares of Personalis by 26.4% in the 3rd quarter. BlackRock Inc. now owns 2,088,283 shares of the company’s stock worth $45,253,000 after buying an additional 436,708 shares during the last quarter. Nikko Asset Management Americas Inc. boosted its stake in shares of Personalis by 16.7% in the 3rd quarter. Nikko Asset Management Americas Inc. now owns 921,413 shares of the company’s stock worth $19,967,000 after buying an additional 131,671 shares during the last quarter. Finally, State Street Corp boosted its stake in shares of Personalis by 4.2% in the 3rd quarter. State Street Corp now owns 361,557 shares of the company’s stock worth $7,835,000 after buying an additional 14,451 shares during the last quarter. Institutional investors and hedge funds own 61.62% of the company’s stock.

In other Personalis news, insider Richard Chen sold 1,087 shares of Personalis stock in a transaction dated Thursday, December 17th. The stock was sold at an average price of $36.37, for a total transaction of $39,534.19. Following the completion of the transaction, the insider now owns 111,370 shares in the company, valued at approximately $4,050,526.90. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Aaron Tachibana sold 2,391 shares of Personalis stock in a transaction dated Thursday, December 17th. The shares were sold at an average price of $36.37, for a total value of $86,960.67. Following the transaction, the chief financial officer now owns 173,291 shares of the company’s stock, valued at approximately $6,302,593.67. The disclosure for this sale can be found here. Insiders have sold a total of 337,045 shares of company stock valued at $9,313,802 in the last quarter. Company insiders own 8.20% of the company’s stock.

About Personalis

Personalis, Inc operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies. It offers NeXT Platform, which provides data for cancer therapy development, personalized therapies, therapy selection, and diagnostics.

Featured Story: How a Put Option Works

Receive News & Ratings for Personalis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Personalis and related companies with MarketBeat.com's FREE daily email newsletter.